![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: FUNDC2 |
Gene summary for FUNDC2 |
![]() |
Gene information | Species | Human | Gene symbol | FUNDC2 | Gene ID | 65991 |
Gene name | FUN14 domain containing 2 | |
Gene Alias | DC44 | |
Cytomap | Xq28 | |
Gene Type | protein-coding | GO ID | GO:0000422 | UniProtAcc | Q9BWH2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
65991 | FUNDC2 | LZE4T | Human | Esophagus | ESCC | 4.71e-17 | 5.43e-01 | 0.0811 |
65991 | FUNDC2 | LZE7T | Human | Esophagus | ESCC | 3.53e-14 | 9.51e-01 | 0.0667 |
65991 | FUNDC2 | LZE8T | Human | Esophagus | ESCC | 1.36e-18 | 5.52e-01 | 0.067 |
65991 | FUNDC2 | LZE20T | Human | Esophagus | ESCC | 4.15e-09 | 3.36e-01 | 0.0662 |
65991 | FUNDC2 | LZE22T | Human | Esophagus | ESCC | 2.91e-05 | 7.04e-01 | 0.068 |
65991 | FUNDC2 | LZE24T | Human | Esophagus | ESCC | 2.63e-32 | 1.12e+00 | 0.0596 |
65991 | FUNDC2 | LZE22D3 | Human | Esophagus | HGIN | 7.19e-03 | 3.78e-01 | 0.0653 |
65991 | FUNDC2 | LZE21T | Human | Esophagus | ESCC | 1.85e-03 | 3.78e-01 | 0.0655 |
65991 | FUNDC2 | LZE6T | Human | Esophagus | ESCC | 7.34e-20 | 1.04e+00 | 0.0845 |
65991 | FUNDC2 | P1T-E | Human | Esophagus | ESCC | 4.63e-10 | 8.67e-01 | 0.0875 |
65991 | FUNDC2 | P2T-E | Human | Esophagus | ESCC | 2.04e-55 | 1.24e+00 | 0.1177 |
65991 | FUNDC2 | P4T-E | Human | Esophagus | ESCC | 8.90e-44 | 9.56e-01 | 0.1323 |
65991 | FUNDC2 | P5T-E | Human | Esophagus | ESCC | 4.85e-21 | 5.22e-01 | 0.1327 |
65991 | FUNDC2 | P8T-E | Human | Esophagus | ESCC | 9.75e-54 | 9.90e-01 | 0.0889 |
65991 | FUNDC2 | P9T-E | Human | Esophagus | ESCC | 3.91e-38 | 1.07e+00 | 0.1131 |
65991 | FUNDC2 | P10T-E | Human | Esophagus | ESCC | 2.60e-73 | 1.40e+00 | 0.116 |
65991 | FUNDC2 | P11T-E | Human | Esophagus | ESCC | 2.91e-32 | 1.09e+00 | 0.1426 |
65991 | FUNDC2 | P12T-E | Human | Esophagus | ESCC | 6.19e-50 | 1.08e+00 | 0.1122 |
65991 | FUNDC2 | P15T-E | Human | Esophagus | ESCC | 4.07e-41 | 8.65e-01 | 0.1149 |
65991 | FUNDC2 | P16T-E | Human | Esophagus | ESCC | 3.79e-30 | 6.61e-01 | 0.1153 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:002241120 | Esophagus | HGIN | cellular component disassembly | 102/2587 | 443/18723 | 8.31e-08 | 4.33e-06 | 102 |
GO:19030089 | Esophagus | HGIN | organelle disassembly | 36/2587 | 114/18723 | 8.60e-07 | 3.58e-05 | 36 |
GO:000042216 | Esophagus | HGIN | autophagy of mitochondrion | 25/2587 | 81/18723 | 5.95e-05 | 1.38e-03 | 25 |
GO:006172616 | Esophagus | HGIN | mitochondrion disassembly | 25/2587 | 81/18723 | 5.95e-05 | 1.38e-03 | 25 |
GO:0022411111 | Esophagus | ESCC | cellular component disassembly | 305/8552 | 443/18723 | 1.94e-23 | 4.57e-21 | 305 |
GO:190300816 | Esophagus | ESCC | organelle disassembly | 89/8552 | 114/18723 | 1.36e-12 | 5.80e-11 | 89 |
GO:000042217 | Esophagus | ESCC | autophagy of mitochondrion | 63/8552 | 81/18723 | 3.41e-09 | 7.24e-08 | 63 |
GO:006172617 | Esophagus | ESCC | mitochondrion disassembly | 63/8552 | 81/18723 | 3.41e-09 | 7.24e-08 | 63 |
GO:00224117 | Liver | Cirrhotic | cellular component disassembly | 182/4634 | 443/18723 | 1.59e-14 | 1.54e-12 | 182 |
GO:19030084 | Liver | Cirrhotic | organelle disassembly | 59/4634 | 114/18723 | 4.82e-10 | 2.27e-08 | 59 |
GO:00004225 | Liver | Cirrhotic | autophagy of mitochondrion | 43/4634 | 81/18723 | 4.02e-08 | 1.31e-06 | 43 |
GO:00617265 | Liver | Cirrhotic | mitochondrion disassembly | 43/4634 | 81/18723 | 4.02e-08 | 1.31e-06 | 43 |
GO:002241112 | Liver | HCC | cellular component disassembly | 282/7958 | 443/18723 | 1.02e-19 | 1.38e-17 | 282 |
GO:190300811 | Liver | HCC | organelle disassembly | 89/7958 | 114/18723 | 8.68e-15 | 5.73e-13 | 89 |
GO:000042211 | Liver | HCC | autophagy of mitochondrion | 64/7958 | 81/18723 | 1.96e-11 | 7.72e-10 | 64 |
GO:006172611 | Liver | HCC | mitochondrion disassembly | 64/7958 | 81/18723 | 1.96e-11 | 7.72e-10 | 64 |
GO:002241119 | Oral cavity | OSCC | cellular component disassembly | 283/7305 | 443/18723 | 9.57e-27 | 3.37e-24 | 283 |
GO:19030088 | Oral cavity | OSCC | organelle disassembly | 85/7305 | 114/18723 | 1.15e-14 | 6.93e-13 | 85 |
GO:000042210 | Oral cavity | OSCC | autophagy of mitochondrion | 59/7305 | 81/18723 | 6.40e-10 | 1.63e-08 | 59 |
GO:006172610 | Oral cavity | OSCC | mitochondrion disassembly | 59/7305 | 81/18723 | 6.40e-10 | 1.63e-08 | 59 |
Page: 1 2 3 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
FUNDC2 | SNV | Missense_Mutation | c.199N>T | p.Arg67Cys | p.R67C | Q9BWH2 | protein_coding | deleterious(0.04) | possibly_damaging(0.628) | TCGA-CG-4465-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | cisplatin | SD | |
FUNDC2 | SNV | Missense_Mutation | c.86N>A | p.Arg29His | p.R29H | Q9BWH2 | protein_coding | deleterious_low_confidence(0.04) | benign(0.277) | TCGA-CG-5726-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
FUNDC2 | SNV | Missense_Mutation | c.544N>C | p.Gly182Arg | p.G182R | Q9BWH2 | protein_coding | deleterious(0.03) | probably_damaging(0.98) | TCGA-HU-A4H5-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Chemotherapy | doxifluridine | SD | |
FUNDC2 | deletion | Frame_Shift_Del | novel | c.336delN | p.Gly113GlufsTer27 | p.G113Efs*27 | Q9BWH2 | protein_coding | TCGA-BR-6852-01 | Stomach | stomach adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |